AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis Businesswire.com, 6 Sep 2011 Accessed on 22 Feb 2012 from http://www.businesswire.com/news/home/20110906006398/en/AB-Science-announces-recruitment-patient-phase-3. CommentRecommendBookmarkWatch